Generic protein substrates in inflammatory exudates and blood

Generic protein substrates in inflammatory exudates and blood is a collective pharmacological term used to describe the various proteins, such as fibrin and bradykinin, that accumulate at sites of tissue injury and inflammation (DrugBank Online, 2024). These substrates are involved in the formation of inflammatory edema and the mediation of pain; fibrin, for example, creates a structural matrix that contributes to swelling, while bradykinin triggers vasodilation and sensitizes pain receptors (Tiwari, 2017, PubMed). Therapeutic proteolytic enzymes, including serratiopeptidase, bromelain, and trypsin, target these proteins to catalyze their breakdown into smaller, inactive peptides (Pavan et al., 2012, Biotechnology Research International). This enzymatic action helps to reduce the viscosity of inflammatory fluids, thereby facilitating their drainage and improving the delivery of other therapeutic agents like antibiotics to the site of infection (Bhagat et al., 2013, Journal of International Medical Research). Although clinically useful for managing post-operative and post-traumatic inflammation, this "target" is considered a non-specific category rather than a single molecular entity.

Other names

Inflammatory exudate proteinsBlood proteinsFibrin and inflammatory mediatorsProteolytic enzyme substratesInflammatory proteins

Proteolytic degradation of fibrin and inflammatory mediators into smaller peptides and amino acids, facilitating the resolution of edema and the inactivation of pain-inducing molecules.